drugset / Trial / NCT07053774
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
RandomizedCrossoverTriple-blindBasic science
Summary
The goal of this research study is to find out how well oxytocin works to reduce pain. Oxytocin will be given intravenously (IV) and as a nasal spray. The study team also hopes to find out if the participants age, weight, or sex effects how well the study drug works. Participants will be exposed to a heater on the skin at a training visit and rate how much pain different temperatures cause. On two separate visits, participants will use a nasal spray and get an IV infusion. After the IV and nasal spray, participants will rate the pain of the same skin heating temperature at various time points for 4 hours.
Timeline
- Start
- 2025-11-05
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 20 iu | Intravenous |
| Subject | Oxytocin | Peptide | 48 iu | Intravenous |
Indications
No indication recorded.